-
NUMBER OF INSIDER BUYING
(Last 12 Months)
0 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
7 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$0 -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$68.53 M
Madrigal Pharmaceuticals, Inc. Insider Transactions
Madrigal Pharmaceuticals, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Waltermire Robert E.
Senior VP, Chief Pharma Dev. |
Sell | 1,900 @ $280.00 | $532,000 | 5,500 | 06/14/2024 | 06/18/2024 | |
|
Waltermire Robert E.
Senior VP, Chief Pharma Dev. |
Sell | 2,000 @ $285.00 | $570,000 | 5,500 | 06/12/2024 | 06/14/2024 | |
|
Waltermire Robert E.
Senior VP, Chief Pharma Dev. |
Sell | 1,036 @ $231.34 | $239,668 | 5,500 | 05/21/2024 | 05/23/2024 | |
|
CRAVES FRED B
Director |
Sell | 2,190 @ $213.85 | $468,342 | 418,462 | 05/14/2024 | 05/16/2024 | |
|
CRAVES FRED B
Director |
Sell | 8,827 @ $210.99 | $1.86 M | 427,024 | 05/14/2024 | 05/16/2024 | |
|
CRAVES FRED B
Director |
Sell | 5,009 @ $211.84 | $1.06 M | 422,015 | 05/14/2024 | 05/16/2024 | |
|
CRAVES FRED B
Director |
Sell | 1,363 @ $212.85 | $290,116 | 420,652 | 05/14/2024 | 05/16/2024 | |
|
CRAVES FRED B
Director |
Sell | 1,804 @ $214.68 | $387,285 | 416,658 | 05/14/2024 | 05/16/2024 | |
|
CRAVES FRED B
Director |
Sell | 721 @ $216.98 | $156,445 | 415,562 | 05/14/2024 | 05/16/2024 | |
|
CRAVES FRED B
Director |
Sell | 375 @ $216.08 | $81,031 | 416,283 | 05/14/2024 | 05/16/2024 | |
|
CRAVES FRED B
Director |
Sell | 1,100 @ $217.86 | $239,641 | 414,462 | 05/14/2024 | 05/16/2024 | |
|
CRAVES FRED B
Director |
Sell | 100 @ $219.90 | $21,990 | 413,362 | 05/14/2024 | 05/16/2024 | |
|
CRAVES FRED B
Director |
Sell | 1,000 @ $218.99 | $218,995 | 413,462 | 05/14/2024 | 05/16/2024 | |
|
Taub Rebecca
Director, Pres., R&D, and CMO |
Sell | 224 @ $243.25 | $54,487 | 461,451 | 04/08/2024 | 04/10/2024 | |
|
Taub Rebecca
Director, Pres., R&D, and CMO |
Sell | 407 @ $247.76 | $100,838 | 459,199 | 04/08/2024 | 04/10/2024 | |
|
FRIEDMAN PAUL A
Director |
Sell | 5,028 @ $246.96 | $1.24 M | 194,065 | 04/08/2024 | 04/10/2024 | |
|
FRIEDMAN PAUL A
Director |
Sell | 3,464 @ $247.76 | $858,241 | 190,601 | 04/08/2024 | 04/10/2024 | |
|
FRIEDMAN PAUL A
Director |
Sell | 4,866 @ $248.59 | $1.21 M | 185,735 | 04/08/2024 | 04/10/2024 | |
|
Taub Rebecca
Director, Pres., R&D, and CMO |
Sell | 945 @ $244.79 | $231,325 | 460,506 | 04/08/2024 | 04/10/2024 | |
|
Taub Rebecca
Director, Pres., R&D, and CMO |
Sell | 300 @ $245.69 | $73,706 | 460,206 | 04/08/2024 | 04/10/2024 |
Madrigal Pharmaceuticals, Inc. Frequently Asked Questions
-
Who is on Madrigal Pharmaceuticals, Inc.'s Insider Roster?
The list of insiders at Madrigal Pharmaceuticals, Inc. includes Daly James M, BATE KENNETH, Levy Richard S, FRIEDMAN PAUL A, Taub Rebecca, CRAVES FRED B, Waltermire Robert E..
-
How much insider selling is happening at Madrigal Pharmaceuticals, Inc.?
Insiders have sold a total of 279,967 Madrigal Pharmaceuticals, Inc. shares in the last 12 months for a total of 68.53 M sold.
-
Which Madrigal Pharmaceuticals, Inc. insiders have been selling company stock?
The following insiders have sold Madrigal Pharmaceuticals, Inc. shares in the last 12 months: Daly James M ($8.22 M), BATE KENNETH ($8.21 M), Levy Richard S ($2.83 M), FRIEDMAN PAUL A ($24.45 M), Taub Rebecca ($18.68 M), CRAVES FRED B ($4.79 M), Waltermire Robert E. ($1.34 M),